Page last updated: 2024-11-05

cumic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cumic acid is a naturally occurring organic compound found in various plants, including cumin, caraway, and oregano. It is a white crystalline solid with a characteristic aromatic odor. Cumic acid is a monocarboxylic acid derived from cumene (isopropylbenzene). It is commonly used in the production of fragrances, pharmaceuticals, and food additives. Cumic acid exhibits various pharmacological properties, including anti-inflammatory, antioxidant, and antimicrobial effects. Research on cumic acid focuses on its potential therapeutic applications, particularly in treating inflammatory conditions, oxidative stress-related diseases, and infections. The compound's ability to inhibit the production of pro-inflammatory mediators and scavenge free radicals makes it a promising candidate for the development of new drugs. Cumic acid has been investigated for its potential to improve cognitive function and memory, as well as its role in regulating blood sugar levels. Further studies are ongoing to explore the full scope of its therapeutic benefits.'

cumic acid : A member of the class of benzoic acids that is cumene substituted by at least one carboxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

p-cumic acid : A cumic acid that consists of benzoic acid substituted by an isopropyl group at position 4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID10820
CHEMBL ID116158
CHEBI ID28122
SCHEMBL ID105270
MeSH IDM0156475

Synonyms (60)

Synonym
AC-2685
CHEBI:28122 ,
4-(propan-2-yl)benzoic acid
p-cumic acid
unii-6lp0wtm1jb
6lp0wtm1jb ,
4-09-00-01843 (beilstein handbook reference)
cumic acid
4-(1-methylethyl)benzoic acid
nsc1907
4-isopropylbenzoic acid
nsc-1907
p-isopropylbenzoic acid
benzoic acid, 4-(1-methylethyl)-
benzoic acid, p-isopropyl-
cuminic acid
ai3-17970
nsc 1907
einecs 208-642-5
brn 1907514
nsc20083
nsc-20083
C06578
536-66-3
4-isopropylbenzoic acid, >=98%
inchi=1/c10h12o2/c1-7(2)8-3-5-9(6-4-8)10(11)12/h3-7h,1-2h3,(h,11,12
STK012850
4-propan-2-ylbenzoic acid
4-isopropyl-benzoic acid
CHEMBL116158
BMSE000662
I0169
AKOS000119633
4-isopropyl benzoic acid
A829718
F3284-7377
FT-0624113
AM20050172
AB01333219-02
SCHEMBL105270
cumic acid [mi]
4iso-propyl benzoic acid
4-iso-propyl benzoic acid
DTXSID6060210
cuminsaure
BS-3886
AE-562/40242410
mfcd00002564
4-(1-methylethyl)benzoic acid, 9ci
4-(1-methylethyl)-benzoic acid
p-isopropyl-benzoic acid
benzoic acid, p-isopropyl- (8ci)
4-isopropylbenzoic acid tech.,gc
CS-W014287
4ia ,
Q1143809
NCGC00341440-01
CK2213
EN300-19994
HY-W013571
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
cumic acidA member of the class of benzoic acids that is cumene substituted by at least one carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1605095Inhibition of N-terminal His6-sumo-tagged full length Staphylococcus aureus ClpP expressed in Escherichia coli BL2 (DE3) at 10 uM pre-incubated for 10 mins before Suc-LY-AMC addition and measured after 1 hr by fluorescence based assay relative to control2020Journal of medicinal chemistry, 03-26, Volume: 63, Issue:6
Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers
AID28731Partition coefficient (logD2.0)1992Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18
Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1060463Inhibition of Sir2p in yeast DMY2844 assessed as growth inhibition after 48 hrs2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Evaluation of benzoic acid derivatives as sirtuin inhibitors.
AID293934Inhibition of pieris rapae Phenoloxidase2007Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5
3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (17.86)18.7374
1990's4 (14.29)18.2507
2000's7 (25.00)29.6817
2010's10 (35.71)24.3611
2020's2 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.46

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.46 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (23.46)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]